Merck KGaA (MKKGY)
OTCMKTS
· Delayed Price · Currency is USD
25.79
-1.97 (-7.10%)
May 15, 2025, 11:42 AM EDT
Merck KGaA Revenue
Merck KGaA had revenue of 5.28B EUR in the quarter ending March 31, 2025, with 3.13% growth. This brings the company's revenue in the last twelve months to 21.32B, up 2.38% year-over-year. In the year 2024, Merck KGaA had annual revenue of 21.16B with 0.78% growth.
Revenue (ttm)
21.32B EUR
Revenue Growth
+2.38%
P/S Ratio
2.75
Revenue / Employee
361.17K EUR
Employees
59,020
Market Cap
60.32B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 21.16B | 163.00M | 0.78% |
Dec 31, 2023 | 20.99B | -1.24B | -5.57% |
Dec 31, 2022 | 22.23B | 2.55B | 12.93% |
Dec 31, 2021 | 19.69B | 2.15B | 12.28% |
Dec 31, 2020 | 17.53B | 1.38B | 8.56% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
Silence Therapeutics | 27.70M |
Merck KGaA News
- 8 hours ago - Merck KGaA Non-GAAP EPS of €2.12, revenue of €5.28B; updates FY25 outlook - Seeking Alpha
- 1 day ago - Germany's Merck drops China surcharge on orders after US-China tariff deal - Reuters
- 15 days ago - SpringWorks: Acquired By Merck KGaA Based On Rare Tumor Targeting Drugs Like OGSIVEO - Seeking Alpha
- 17 days ago - Germany's Merck Agrees to Buy US Biotech SpringWorks Therapeutics for Almost $4B - Investopedia
- 17 days ago - Wall Street Breakfast Podcast: Huawei Preps AI Chip To Challenge Nvidia: Report - Seeking Alpha
- 17 days ago - Santé : Merck KGaA acquiert l'américain SpringWorks Therapeutics pour 3,4 milliards de dollars - Le Figaro
- 17 days ago - Merck KGaA (MKGAF) to Acquire SpringWorks Therapeutics for $3.9 Billion - GuruFocus
- 17 days ago - Merck KGaA to Acquire SpringWorks Therapeutics for $3.9 Billion | SWTX stock news - GuruFocus